Diabetes: Metformin in breast cancer

Nature Reviews Endocrinology 13, 251 (2017).
doi:10.1038/nrendo.2017.37

Author: Conor A. Bradley
A new study published in the Journal of Clinical Oncology reports that metformin improves the prognosis of patients with HER2-positive, hormone receptor (HR)-positive breast cancer and diabetes mellitus.The phase III randomized ALTTO trial included patients with early-stage, surgically resected HER2-positive breast cancer and

Source: Nature Reviews Endocrinology - March 31, 2017 Category: Endocrinology Authors: Conor A. Bradley Tags: Research Highlight Source Type: research